Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
7.27M
-
Shares change
-
-507K
-
Total reported value, excl. options
-
$235M
-
Value change
-
-$25.7M
-
Put/Call ratio
-
1.03
-
Number of buys
-
52
-
Number of sells
-
-63
-
Price
-
$32.34
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2020
152 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2020.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.27M shares
of 22.3M outstanding shares and own 32.61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.53M shares), VANGUARD GROUP INC (549K shares), DIMENSIONAL FUND ADVISORS LP (496K shares), STATE STREET CORP (305K shares), FEDERATED HERMES, INC. (301K shares), THOMPSON SIEGEL & WALMSLEY LLC (299K shares), INVESTMENT COUNSELORS OF MARYLAND LLC (279K shares), Global Alpha Capital Management Ltd. (275K shares), GOLDMAN SACHS GROUP INC (274K shares), and RENAISSANCE TECHNOLOGIES LLC (173K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.